Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mitomycin-C with Bladder Wall Hyperthermia in NMIBC
NCT03694535Completed
- Sponsor
- Erciyes University
- Start
- Jan 2012
- Primary completion
- Feb 2015
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of mitomycin c in Non-muscle-invasive bladder cancer (NMIBC), sponsored by Erciyes University. Primary endpoints: Recurrence at 2 years and Progression rate at 2 years. Started Jan 2012; status: completed.
02
Drugs
mitomycin c
03
Conditions
Non-muscle-invasive bladder cancer (NMIBC)
Beyond the preview
Go deeper on NCT03694535.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03694535.